Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

NASDAQ:EPSN - Nasdaq - CA2943752097 - Common Stock - Currency: USD

7.5  -0.02 (-0.27%)

After market: 7.6 +0.1 (+1.33%)

Fundamental Rating

5

EPSN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. EPSN has an excellent financial health rating, but there are some minor concerns on its profitability. EPSN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year EPSN was profitable.
In the past year EPSN had a positive cash flow from operations.
EPSN had positive earnings in each of the past 5 years.
In the past 5 years EPSN always reported a positive cash flow from operatings.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

With a Return On Assets value of 3.54%, EPSN perfoms like the industry average, outperforming 51.66% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.45%, EPSN is in line with its industry, outperforming 44.08% of the companies in the same industry.
With a Return On Invested Capital value of 5.62%, EPSN perfoms like the industry average, outperforming 48.82% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EPSN is significantly below the industry average of 23.70%.
The last Return On Invested Capital (5.62%) for EPSN is well below the 3 year average (10.21%), which needs to be investigated, but indicates that EPSN had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.54%
ROE 4.45%
ROIC 5.62%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

EPSN's Profit Margin of 11.18% is in line compared to the rest of the industry. EPSN outperforms 59.72% of its industry peers.
In the last couple of years the Profit Margin of EPSN has declined.
Looking at the Operating Margin, with a value of 26.81%, EPSN is in the better half of the industry, outperforming 62.09% of the companies in the same industry.
EPSN's Operating Margin has declined in the last couple of years.
The Gross Margin of EPSN (73.51%) is better than 85.31% of its industry peers.
EPSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.81%
PM (TTM) 11.18%
GM 73.51%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

EPSN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
EPSN has less shares outstanding than it did 1 year ago.
EPSN has less shares outstanding than it did 5 years ago.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

EPSN has an Altman-Z score of 4.06. This indicates that EPSN is financially healthy and has little risk of bankruptcy at the moment.
EPSN has a Altman-Z score of 4.06. This is amongst the best in the industry. EPSN outperforms 87.68% of its industry peers.
EPSN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.06
ROIC/WACC0.61
WACC9.2%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.66 indicates that EPSN should not have too much problems paying its short term obligations.
The Current ratio of EPSN (1.66) is better than 72.04% of its industry peers.
EPSN has a Quick Ratio of 1.66. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.66, EPSN is in the better half of the industry, outperforming 74.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.66
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.39% over the past year.
EPSN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.77% yearly.
Looking at the last year, EPSN shows a very strong growth in Revenue. The Revenue has grown by 35.22%.
Measured over the past years, EPSN shows a small growth in Revenue. The Revenue has been growing by 3.38% on average per year.
EPS 1Y (TTM)17.39%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%157.14%
Revenue 1Y (TTM)35.22%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%102.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

EPSN is valuated quite expensively with a Price/Earnings ratio of 27.78.
EPSN's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.45. EPSN is around the same levels.
Based on the Price/Forward Earnings ratio of 15.32, the valuation of EPSN can be described as correct.
EPSN's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of EPSN to the average of the S&P500 Index (21.90), we can say EPSN is valued slightly cheaper.
Industry RankSector Rank
PE 27.78
Fwd PE 15.32
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

60.19% of the companies in the same industry are more expensive than EPSN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.22
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

EPSN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

EPSN has a Yearly Dividend Yield of 3.33%.
Compared to an average industry Dividend Yield of 6.51, EPSN has a dividend in line with its industry peers.
EPSN's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.33%

5.2 History

EPSN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

123.78% of the earnings are spent on dividend by EPSN. This is not a sustainable payout ratio.
DP123.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

More info and screens

EPSILON ENERGY LTD

NASDAQ:EPSN (7/3/2025, 7:20:15 PM)

After market: 7.6 +0.1 (+1.33%)

7.5

-0.02 (-0.27%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-11 2025-08-11
Inst Owners62.4%
Inst Owner Change-79.12%
Ins Owners4.6%
Ins Owner Change2.75%
Market Cap165.15M
Analysts82.86
Price Target8.57 (14.27%)
Short Float %0.67%
Short Ratio0.66
Dividend
Industry RankSector Rank
Dividend Yield 3.33%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP123.78%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-13 2025-06-13 (0.0625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.56%
Min EPS beat(2)-41.18%
Max EPS beat(2)26.05%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)16.19%
Min Revenue beat(2)-2.91%
Max Revenue beat(2)35.29%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.34%
Valuation
Industry RankSector Rank
PE 27.78
Fwd PE 15.32
P/S 4.16
P/FCF N/A
P/OCF 7.6
P/B 1.66
P/tB 1.66
EV/EBITDA 7.22
EPS(TTM)0.27
EY3.6%
EPS(NY)0.49
Fwd EY6.53%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.99
OCFY13.15%
SpS1.8
BVpS4.53
TBVpS4.53
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 4.45%
ROCE 9.16%
ROIC 5.62%
ROICexc 5.97%
ROICexgc 5.97%
OM 26.81%
PM (TTM) 11.18%
GM 73.51%
FCFM N/A
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexcg growth 3Y-47.2%
ROICexcg growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 212.4%
Cap/Sales 60.35%
Interest Coverage 608.25
Cash Conversion 99.07%
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 1.66
Altman-Z 4.06
F-Score7
WACC9.2%
ROIC/WACC0.61
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.39%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%157.14%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.22%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%102.29%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y114.8%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year537.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-107.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.67%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%